 |
Most studied contents |
 |
Editorial Board ( 43804 view) |
 |
About Journal ( 31187 view) |
 |
Indexing &Abstracting ( 22660 view) |
 |
Submission Instruction ( 21330 view) |
 |
Contact Information ( 19617 view) |
 |
Call for Papers ( 17957 view) |
 |
Aims and Scope ( 17808 view) |
 |
Open Access Policy ( 16754 view) |
 |
Reviewers List ( 16572 view) |
 |
Call for paper for special issue on Nanoscience and Nanotechnology ( 14845 view) |
 |
CrossMark Policy ( 14427 view) |
 |
Is COVID-19 Risk Linked to Blood Type? ( 13887 view) |
 |
Ethical Principles for Psychological Research ( 12982 view) |
 |
Peer Review policy ( 11988 view) |
 |
Publishing Ethics ( 11917 view) |
 |
Policies of Peer Review ( 10656 view) |
 |
Registration Information ( 9087 view) |
 |
Conflicts of Interest ( 8997 view) |
 |
Ethical Principles for Medical Research ( 8968 view) |
 |
Editorial policies ( 8759 view) |
 |
Compatibility of Commonly Used IV Drugs ( 8134 view) |
 |
COVID-19 resources: serological tests, face masks and benefits of physical activity ( 6838 view) |
 |
NCPA 2024: In Spite of Challenges, Independent Pharmacies Are Continuing to Serve Patients ( 6737 view) |
 |
FDA Approves Vegzelma, a Biosimilar to Bevacizumab, for Six Types of CancerFDA Approves Vegzelma, a Biosimilar to Bevacizumab, for Six Types of Cancer ( 6611 view) |
 |
Social isolation can lead to depression in children long after current lockdown ( 6446 view) |
 |
International Conference on Cell Science and Molecular Biology December 02-04, 2021 Rome, Italy ( 6314 view) |
 |
Navigating FDA Compounding Regulations: Tirzepatide's Removal From the Shortage List and Its Impact on 503A and 503B Facilities ( 6166 view) |
 |
Study Finds Behaviors of Breast Cancer Cells Help Predict Risk of Bone Metastasis ( 6107 view) |
 |
Webinars for the Week of July 6th ( 5977 view) |
 |
What do we know for sure about hydroxychloroquine for COVID-19? Not much ( 5824 view) |
 |
Is the PASTEUR Act the Correct Way to Tackle Antibiotic Resistance? ( 5810 view) |
 |
FDA Grants Orphan Drug Designation to CAP-002 to Treat Patients With Developmental and Epileptic Encephalopathy ( 5796 view) |
 |
Happy Peer Review Week from ACS Publications ( 5794 view) |
 |
Upcoming Events of the ACSE ( 5776 view) |
 |
Introduction to testing for COVID-19 ( 5773 view) |
 |
COVID-19 Anticoagulation Trials 'Paused' for Futility, Safety ( 5716 view) |
 |
Pharmacists Play Key Role in Flu Vaccination Efforts ( 5705 view) |
 |
Korean Biopharmaceutical Firm Celltrion Launches Both Antigen and Antibody Testing Kits in the US ( 5705 view) |
 |
Researchers Find Lack of Communication for Lung Cancer Screenings Among High-Risk Individuals ( 5620 view) |
 |
Vitamin D Supplementation Could Aid Pediatric Obstructive Sleep Apnea ( 5571 view) |
 |
Patients With Endometriosis Have an Increased Risk of Developing Cardiovascular Disease ( 5562 view) |
 |
Increase in Pharmacy First monthly payment threshold delayed to January 2025 ( 5533 view) |
 |
From Brain to Behavior: The Search for Biomarkers ( 5528 view) |
 |
Almost 50 hospitalised after taking weight loss drugs, warns MHRA ( 5526 view) |
 |
Poor cardiovascular health may contribute to the development of musculoskeletal disorders ( 5499 view) |
 |
Share your COVID experiences with 2 million+ researchers ( 5409 view) |
 |
NCPA 2024: Latest Updates on Respiratory Vaccines ( 5405 view) |
 |
COVID-19: Bacteriophage Could Decrease Mortality ( 5201 view) |
 |
FDA approves generic albuterol inhaler to mitigate shortages during pandemic ( 5108 view) |
 |
Animal Models of COVID-19 ( 5104 view) |